Cell Culture Technology– category –
-
Kincell Bio Inaugurates and Expands State-of-the-Art GMP Cell Therapy Manufacturing Facilities in Gainesville and Research Triangle Park
Kincell Bio USA Overview Kincell Bio has opened and expanded GMP cell therapy manufacturing facilities in Gainesville, Florida, and Research Triangle Park, North Carolina, designed to support both autologous and allogeneic cell therapies... -
EU-Funded S.O.L.A.R.I.S. Project Launched to Enhance Scalability, Efficiency, and Sustainability of CAR T Cell Manufacturing Across Europe
Green Elephant Biotech Germany Overview The EU-funded S.O.L.A.R.I.S. Project has commenced with 13 partners, including Green Elephant Biotech and Miltenyi Biotec, aiming to develop and implement new approaches for scalable, efficient, an... -
OXB Accelerates Gene Therapy Production for Plowshare Therapies, Leveraging FDA-Approved AAV Manufacturing in North Carolina
Markets Insider UK Overview OXB has partnered with Plowshare Therapies to provide crucial process development and GMP manufacturing for Plowshare’s AAV gene therapy program. This collaboration leverages OXB's FDA-approved commercial-scal... -
Continuous Bioprocessing Delivers Significant Gains in Biopharmaceutical Manufacturing Efficiency and Cost Reduction, Driven by 500L Single-Use Perfusion Bioreactors
BioProcess International USA Overview Biopharmaceutical manufacturers are rapidly adopting continuous bioprocessing, integrating upstream cell culture and downstream operations to boost productivity, cut costs, and reduce facility footpr... -
ADM and Every Partner to Scale Precision Fermentation of Animal-Free Egg Protein ‘OvoPro’ by 550% at Clinton, Iowa Facility
Food Dive USA Overview ADM and Every are partnering to significantly scale the commercial production of OvoPro, an animal-free egg protein produced via precision fermentation, at ADM's Clinton, Iowa facility. This collaboration aims to b... -
Umoja Biopharma Secures FDA IND Clearance for UB-VV400, First-in-Industry CD22-Targeted In Vivo CAR T Cell Therapy for Relapsed/Refractory B-Cell Malignancies
Umoja Biopharma (Press Release) USA Overview Umoja Biopharma has received FDA Investigational New Drug (IND) clearance for UB-VV400, a CD22-targeted in vivo CAR T cell therapy candidate for relapsed/refractory B-cell malignancies. This m... -
Roche Leverages NVIDIA AI Digital Twins for GLP-1 Biomanufacturing Innovation, Targeting 25-40% Capacity Increase and 15-20% Lead Time Reduction
IntuitionLabs Switzerland Overview Roche announced the integration of NVIDIA's AI and digital twin technologies, including BioNeMo, to optimize its biomanufacturing processes for GLP-1 pharmaceuticals. This initiative aims to create virt... -
Kincell Bio Unveils Scalable Allogeneic Cell Therapy Manufacturing Platform for Large-Scale Production with Closed-System Automation
Kincell Bio USA Overview Kincell Bio has launched a scalable allogeneic cell therapy manufacturing platform designed for large-volume production, efficient cell expansion, and closed-system automation. This platform supports diverse cell... -
New Manufacturing-Scale Cell Culture Media Preparation Guide Optimizes Quality and Efficiency with WFI Temperature Control (15-25°C) and Filtration Sizing (0.5-2m²/1000L)
BioProcess Tools Global Overview A new guideline for manufacturing-scale cell culture media preparation emphasizes that media quality directly impacts cell growth, viable cell density, and product titer. Achieving pharmaceutical-grade pr... -
Fujifilm Diosynth Commits $2 Billion to North Carolina Gene Therapy Facility Amid Supply Chain Shifts; India Emerges as Key CDMO Hub
BioSpace Global Overview Fujifilm Diosynth is investing approximately $2 billion in a new gene therapy manufacturing facility in North Carolina, strategically positioning against global supply chain shifts. Catalent, under Novo Holdings,...
